WASHINGTON (Legal Newsline) — The U.S. Department of Justice announced Sept. 26 that two companies in New Jersey, as well as two individuals, have been banned from distributing injectable skin whitening drugs and other medicines that have not been approved by the U.S. Food and Drug Administration (FDA).
“The Department of Justice is committed to enforcing federal consumer protection laws,” said acting assistant attorney general Chad A. Readler of the Justice Department’s Civil Division. “We will continue to work diligently with the FDA to ensure that companies and individuals follow the laws designed to protect American consumers.”
The defendants in the case are Flawless Beauty LLC of Ocean Township and Asbury Park, New Jersey, RDG Imports LLC of Asbury Park, and Jack H. Gindi and Susana B. Boleche.
“Distributing unapproved drugs and mislabeling them to give the impression that they have been approved by the FDA is a practice that cannot be tolerated,” said acting U.S. attorney William E. Fitzpatrick of the District of New Jersey. “This decree ensures that these products will be removed from the marketplace and that the defendants will not be allowed to distribute them until they bring the products into compliance with the law.”